T1	Treatment 0 10	Argatroban
T2	Treatment 161 171	argatroban
T3	Treatment 207 247	percutaneous coronary intervention (PCI)
T4	Treatment 317 327	Argatroban
T5	Treatment 444 454	argatroban
T6	Treatment 584 594	argatroban
T7	Treatment 688 698	argatroban
T8	Treatment 711 726	(ARG250, ARG300
T9	Treatment 732 738	ARG350
T10	Treatment 826 858	one unfractionated heparin (UFH)
T11	Treatment 905 914	analyzed.
T12	Treatment 915 925	Argatroban
T13	Treatment 1058 1091	injection (ARG250: 86.1%, ARG300:
T14	Treatment 1099 1110	and ARG350:
T15	Treatment 1263 1276	in argatroban
T16	Treatment 1282 1288	in UFH
T17	Treatment 1347 1370	shortened in argatroban
T18	Treatment 1520 1563	groups (ARG250: 2.8%, ARG300: 0.0%, ARG350:
T19	Treatment 1569 1572	vs.
T20	Treatment 1613 1620	only in
T21	Treatment 1654 1672	occurred in ARG350
T22	Treatment 1680 1683	and
T23	Treatment 1702 1723	CONCLUSION Argatroban
T24	Treatment 1779 1790	compared to
T25	Treatment 1865 1884	undergoing elective
